A visionary leader in bioprocessing and downstream processing, Dr. Pal founded Exonova LifeSciences with the mission of bridging cutting-edge scientific advancements and accessible healthcare solutions. She holds a distinguished DAAD Fellowship at IPK Gatersleben, Germany, and postdoctoral fellowships at IIT Delhi and JNU Delhi— widely recognised as a pioneer in bioscience innovation.
Over two decades of global drug development experience across oncology, rare diseases, neurology, and cardiovascular medicine. Senior leadership at Dyne Therapeutics, Amgen, Genzyme, and Biogen. Leads Exonova's clinical strategy and EV-based therapeutics regulatory readiness.
Focuses on harnessing exosomes as non-invasive biomarkers for early-stage Parkinson’s disease and breast cancer. Pioneers FTIR-based infrared imaging for cost-effective diagnostics.
Leads the G-INCs Laboratory at the University of Ottawa, engineering nanoparticle systems for cancer, cardiovascular, and inflammatory diseases. 60+ publications, 6,000+ citations. Previously at Brigham and Women's Hospital and Harvard Medical School.
Postdoctoral research at IIT Hyderabad on tissue engineering and vaccine delivery. Advances extracellular vesicle use in diagnostics, prophylaxis, and therapeutics — including bioactive wound dressings and nanostructured platforms for drug and vaccine delivery.
Doctorate from JNU in Cellular and Molecular Biology of Infectious Diseases. Specialises in TB pathomechanisms and microbial pathogenesis with 30+ peer-reviewed articles in Autophagy and Frontiers in Immunology. Review editor for Gut Pathogens.
Over a decade of expertise in nanobiotechnology, enzyme engineering, and microbial nanotechnology. 3,500+ citations, H-index 28, i10-index 40. Reasearch spans nanoparticle-assisted enzyme immobilization, microbial nanofactories, and bioactive nanomaterials – supporting Exonova’s biologically derived nanocarrier and EV technology development.
A Bachelor of Medical Laboratory Technology (BMLT) graduate bringing hands-on laboratory expertise to Exonova's operations. As Application Specialist, Mr. Kumar supports the practical deployment and application of Exonova's extracellular vesicle technologies, bridging the gap between research innovation and real-world laboratory workflows.
